Personal information

No personal information available

Activities

Collapse all

Works (10)

A Novel AMPK Inhibitor Sensitizes Pancreatic Cancer Cells to Ferroptosis Induction

Advanced Science
2024-08 | Journal article
DOI: 10.1002/advs.202307695
Part of ISSN: 2198-3844
Part of ISSN: 2198-3844
Contributors: Carolin Schneider; Jorina Hilbert; Franziska Genevaux; Stefanie Höfer; Lukas Krauß; Felix Schicktanz; Constanza Tapia Contreras; Shaishavi Jansari; Aristeidis Papargyriou; Thorsten Richter et al.
Source: Self-asserted source
Felix Orben

Comparison of endoscopic ultrasound-guided fine-needle aspiration and fine-needle biopsy to generate pancreatic cancer organoids: Randomized trial

Endoscopy International Open
2024-03 | Journal article
DOI: 10.1055/a-2257-3171
Part of ISSN: 2364-3722
Part of ISSN: 2196-9736
Contributors: 0000-0002-0471-1462; Felix Orben; Arlett Schäfer; Lisa Fricke; Günter Schneider; Maximilian Reichert; Alexander Herner; Ulrich Mayr; Veit Phillip; Matthias Treiber et al.
Source: Self-asserted source
Felix Orben

Human JAK1 gain of function causes dysregulated myelopoeisis and severe allergic inflammation

JCI Insight
2022-12-22 | Journal article
DOI: 10.1172/jci.insight.150849
Contributors: Catherine M. Biggs; Anna Cordeiro-Santanach; Sergey V. Prykhozhij; Adam P. Deveau; Yi Lin; Kate L. Del Bel; Felix Orben; Robert J. Ragotte; Aabida Saferali; Sara Mostafavi et al.
Source: check_circle
Crossref

Epigenetic drug screening defines a PRMT5 inhibitor–sensitive pancreatic cancer subtype

JCI Insight
2022-05-23 | Journal article
DOI: 10.1172/jci.insight.151353
Contributors: Felix Orben; Katharina Lankes; Christian Schneeweis; Zonera Hassan; Hannah Jakubowsky; Lukas Krauß; Fabio Boniolo; Carolin Schneider; Arlett Schäfer; Janine Murr et al.
Source: check_circle
Crossref

Indirect targeting of MYC sensitizes pancreatic cancer cells to mechanistic target of rapamycin (mTOR) inhibition

Cancer Communications
2022-04 | Journal article
DOI: 10.1002/cac2.12280
Contributors: Christian Schneeweis; Zonera Hassan; Katja Ascherl; Matthias Wirth; Stella Koutsouli; Felix Orben; Lukas Krauß; Carolin Schneider; Rupert Öllinger; Oliver H. Krämer et al.
Source: check_circle
Crossref

Identification of treatment‐induced vulnerabilities in pancreatic cancer patients using functional model systems

EMBO Molecular Medicine
2022-04-07 | Journal article
DOI: 10.15252/emmm.202114876
Contributors: Katja Peschke; Hannah Jakubowsky; Arlett Schäfer; Carlo Maurer; Sebastian Lange; Felix Orben; Raquel Bernad; Felix N Harder; Matthias Eiber; Rupert Öllinger et al.
Source: check_circle
Crossref

NOXA expression drives synthetic lethality to RUNX1 inhibition in pancreatic cancer

Proceedings of the National Academy of Sciences
2022-03 | Journal article
DOI: 10.1073/pnas.2105691119
Contributors: Josefina Doffo; Stefanos A. Bamopoulos; Hazal Köse; Felix Orben; Chuanbing Zang; Miriam Pons; Alexander T. den Dekker; Rutger W. W. Brouwer; Apoorva Baluapuri; Stefan Habringer et al.
Source: check_circle
Crossref

A novel Cereblon E3 ligase modulator with antitumor activity in gastrointestinal cancer

Bioorganic Chemistry
2021-11 | Journal article
DOI: 10.1016/j.bioorg.2021.105505
Part of ISSN: 0045-2068
Source: Self-asserted source
Felix Orben

SUMO pathway inhibition targets an aggressive pancreatic cancer subtype

Gut
2020-08 | Journal article
DOI: 10.1136/gutjnl-2018-317856
Part of ISSN: 0017-5749
Part of ISSN: 1468-3288
Source: Self-asserted source
Felix Orben

Implementing cell-free DNA of pancreatic cancer patient-derived organoids for personalized oncology

JCI Insight
2020-07-02 | Journal article
Part of DOI: 10.1172/jci.insight.137809
Part of ISSN: 2379-3708
Source: Self-asserted source
Felix Orben
How many people are using ORCID?